Back

Sex-specific prognostic implications of new-onset atrial fibrillation in patients treated with dual chamber pacemakers

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation detection, prediction, and management Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Sofia Marinko

Lund (Sweden)

6 More presentations in this session

Presentation thumbnail
Impact of atrial fibrillation on cardiac autonomic function in elderly patients
Doctor P. Haemmerle (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Circadian rhythm in atrial fibrillation detected by implantable loop recorder: a post-hoc analysis of a randomized clinical trial
Mr D. Spona (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
To monitor or not after detected AF, this is a question: report from the consumer-led screening programme of long-term extension mAFA cohort
Professor Y. Guo (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Quality of life after screening for atrial fibrillation: a substudy from a randomised screening trial
Doctor E. Kongebro (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Heart rate variability to predict 1-day atrial fibrillation episode onset using machine learning
Professor S. Carlier (Mons, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation detection, prediction, and management

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Unveiling atrial fibrillation post-pacemaker implantation: insights into incidence and predictive factors
thumbnail
Congress Presentation
Unraveling gender's influence: a detailed analysis of mortality and acute heart failure risk in HFpEF Patients post-pacemaker Implantation
thumbnail
Congress Presentation
The effect of gender on prognosis in patients with sinus rhythm and in patients with atrial fibrillation in heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources